HIGHLIGHTS
- who: Gloria Brusotti from the 0126, Bari, Italy Inserm UMR, Faculté de Médecine Timone, Aix-Marseille University, bd Jean Moulin have published the research work: Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis, in the Journal: Scientific Reports Scientific Reports of 23/01/2017
- what: The results of this study show that the natural compound BA could be an interesting and safe candidate for the treatment of type 2 diabetes and bone diseases.
SUMMARY
The procedure described in Methods allowed a high protein . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.